Jelly-like Potassium Iodide Composition for Infant Administration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current iodine preparations, such as potassium iodide pills and powders, face challenges in ease of intake and storage stability, particularly for infants and newborns, and require pulverization or dissolution in water, which is difficult in emergency situations, and existing liquid preparations have issues with intake ease.
Innovation Solution
A jelly-like pharmaceutical composition comprising potassium iodide, a gelling agent (like carrageenan or xanthan gum), and a dispersion medium, with optional stabilizers, sweeteners, buffers, and preservatives, designed for easy administration and storage, packaged in an air-push type stick-like container.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If a potassium iodide pill is used, then storage stability is improved, but ease of intake deteriorates for infants requiring pulverization
Solution Approach 1:
The invention divides the single 50mg pill into multiple smaller dosage units (e.g., 16.3mg for newborns, 32.5mg for infants). Each small unit is pre-portioned and requires no pulverization, making it easy to administer to infants while maintaining storage stability of the individual units.
Solution Approach 2:
The invention changes the physical form parameter from solid pill to a dissolvable format (powder, granule, or liquid) that can be easily administered to infants. This parameter change maintains the active ingredient potency while improving ease of intake for different age groups.
2Ease of operation
If potassium iodide bulk powder is dissolved in water for infant administration, then ease of intake is improved, but device complexity and difficulty of operation increase in emergency situations
Solution Approach 1:
The invention performs preliminary action by pre-dissolving the potassium iodide in a suitable vehicle during manufacturing to create a ready-to-administer liquid or semi-liquid formulation. This eliminates the need for on-site dissolution during emergencies, reducing administration complexity while maintaining ease of intake.
Solution Approach 2:
The invention introduces a suitable vehicle or carrier as an intermediary substance that facilitates direct administration of potassium iodide to infants. This intermediary eliminates the need for water dissolution by the administrator, simplifying the emergency response process.
3Ease of operation
If a liquid iodine preparation is used, then ease of intake is improved, but storage stability deteriorates
Solution Approach 1:
The invention optimizes the physical and chemical parameters of the liquid formulation, including pH adjustment, concentration control, and selection of stable vehicles or carriers. These parameter changes enhance storage stability while maintaining the liquid form's ease of administration to infants.
Solution Approach 2:
The invention uses composite material systems combining potassium iodide with stabilizing agents, buffers, and suitable vehicles. This composite formulation maintains liquid state for easy administration while the combined materials provide enhanced storage stability through chemical stabilization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The jelly-like composition provides excellent storage stability and dissolution properties, making it easy to administer to infants and newborns, and can be stored for a certain period, ensuring effective prevention of internal iodine exposure in emergencies.
Implementation Method 1
A jelly-like pharmaceutical composition comprises potassium iodide as an active ingredient, a gelling agent, and a dispersion medium
Data Source
AI summary
A jelly-like potassium iodide pharmaceutical composition exhibits excellent storage stability and excellent dissolution properties, and can be taken easily. The jelly-like potassium iodide pharmaceutical composition includes potassium iodide as an active ingredient, a gelling agent, and a dispersion medium.